Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 4/2015

01-04-2015 | Headache (RB Halker, Section Editor)

Behavioral Treatments for Migraine Management: Useful at Each Step of Migraine Care

Authors: Alexandra B. Singer, Dawn C. Buse, Elizabeth K. Seng

Published in: Current Neurology and Neuroscience Reports | Issue 4/2015

Login to get access

Abstract

Migraine is a disabling and prevalent disorder. Migraine is most effectively treated with a stepped care approach, where patients initially receive a broad level of care (primary care) and proceed to receive increasingly specialized care throughout the course of treatment. Behavioral treatments for migraine modify behaviors of people with migraine with the intention to prevent migraine episodes and secondary consequence of migraine. Behavioral treatments can be incorporated into each level of the stepped care approach for migraine treatment. In this article, we provide a rationale for including behavioral treatment strategies in the treatment of migraine. We then describe and review the evidence for behavioral treatment strategies for migraine, including patient education, relaxation strategies, biofeedback, and cognitive behavioral treatment strategies. Finally, we describe how behavioral treatments can be integrated into a stepped care approach for migraine care.
Literature
1.
Lipton RB et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.CrossRefPubMed
2.
Smitherman TA et al. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53(3):427–36. Provides a review of epidemiologic investigations of migraine and severe headaches in the United States, including information about prevalence, impact of migraine on patient’s lives, and treatment of migraine. CrossRefPubMed
3.
Murray C. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Los Angeles: Harvard University Press; 1996.
4.
Bower P, Gilbody S. Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. Br J Psychiatry. 2005;186:11–7.CrossRefPubMed
5.
6.
Silberstein S. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Neurology. 2000;55(6):754–62.CrossRefPubMed
7.
Penzien D, Rains J, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback. 2002;27:163–81.CrossRefPubMed
8.
Schwartz MS, Andrasik F. Biofeedback: a practitioner’s guide. 3rd ed. New York: Guilford Press; 2003.
9.
Buse DC. Multidisciplinary migraine management. Pain Med News. 2014;12.
10.
Pesa J, Lage MJ. The medical costs of migraine and comorbid anxiety and depression. Head J Head Face Pain. 2004;44(6):562–70.CrossRef
11.
Hawkins K, Wang S, Rupnow M. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49(4):368–74.CrossRefPubMed
12.
Stokes M et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache. 2011;51(7):1058–77.CrossRefPubMed
13.
Schafer AM et al. Direct costs of preventive headache treatments: comparison of behavioral and pharmacologic approaches. Headache. 2011;51(6):985–91. Provides evidence for the cost-effectiveness of behavioral approaches for headache prevention. CrossRefPubMedCentralPubMed
14.
Haddock CK et al. Home-based behavioral treatments for chronic benign headache: a meta-analysis of controlled trials. Cephalalgia. 1997;17(2):113–8.CrossRefPubMed
15.
Rains J, Lipchik G, Penzien D. Behavioral facilitation of medical treatment for headache. Part I: review of headache treatment compliance. Head J Head Face Pain. 2006;46(9):1387–94.CrossRef
16.
Peters M et al. Patients’ decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia. 2003;23(8):833–41.CrossRefPubMed
17.
Seng EK, Holroyd KA. Optimal use of acute headache medication: a qualitative examination of behaviors and barriers to their performance. Headache. 2013;53(9):1438–50.PubMed
18.
Ramsey RR et al. Treatment adherence in patients with headache: a systematic review. Headache. 2014;54(5):795–816. A thorough systematic review of all types of treatment adherence (acute medications, preventive medications, lifestyle recommendations and behavioral management strategies) for headache disorders. CrossRefPubMed
19.
20.
Andrasik F et al. Disability in chronic migraine with medication overuse: treatment effects at 3 years. Headache. 2007;47(9):1277–81.CrossRefPubMed
21.
Rains JC, Penzien DB, Lipchik GL. Behavioral facilitation of medical treatment for headache—part II: theoretical models and behavioral strategies for improving adherence. Headache. 2006;46(9):1395–403.CrossRefPubMed
22.
Dunbar-Jacob J et al. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90.PubMed
23.
Seng EK, Holroyd KA. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Ann Behav Med. 2010;40(3):235–47.CrossRefPubMed
24.
Nestoriuc Y et al. Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2008;33(3):125–40.CrossRefPubMed
25.
Blumenfeld A, Tischio M. Center of excellence for headache care: group model at Kaiser Permanente. Headache. 2003;43(5):431–40.CrossRefPubMed
26.
Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache. 2002;42(9):845–54.CrossRefPubMed
27.
Rothrock JF et al. The impact of intensive patient education on clinical outcome in a clinic-based migraine population. Headache. 2006;46(5):726–31.CrossRefPubMed
28.
Harpole LH et al. Headache management program improves outcome for chronic headache. Headache. 2003;43(7):715–24.CrossRefPubMed
29.
Holroyd KA et al. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training. Headache. 1989;29(3):148–53.CrossRefPubMed
30.
Cameron C. Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens. J Adv Nurs. 1996;24(2):244–50.CrossRefPubMed
31.
Cady R et al. Nurse-based education: an office-based comparative model for education of migraine patients. Headache. 2008;48(4):564–9.CrossRefPubMed
32.
33.
Holroyd KA et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010;341:c4871.CrossRefPubMedCentralPubMed
34.
Cady RK et al. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response. Headache. 2009;49(5):687–96.CrossRefPubMed
35.
Hahn SR et al. Healthcare provider–patient communication and migraine assessment: results of the American Migraine Communication Study, phase II. Curr Med Res Opin. 2008;24(6):1711–8.CrossRefPubMed
36.
Boyle D, Dwinnell B, Platt F. Invite, listen, and summarize: a patient-centered communication technique. Acad Med. 2005;80(1):29–32.CrossRefPubMed
37.
Benson H, Greenwood MM, Klemchuk H. The relaxation response: psychophysiologic aspects and clinical applications. Int J Psychiatry Med. 1975;6(1–2):87–98.CrossRefPubMed
38.
Jacobson E. Progressive relaxation. Chicago: University of Chicago Press; 1938.
39.
Hall H. Hypnosis. In: Waldman S, editor. Pain management. Philadelphia: Saunders/Elsevier; 2011. p. 963–6.CrossRef
40.
Rime C, Andrasik F. Relaxation techniques and guided imagery. In: Waldman S, editor. Pain management. Philadelphia: Saunders/Elsevier; 2011. p. 967–75.CrossRef
41.
Smith JC. Relaxation, meditation & mindfulness: a mental health practitioner’s guide to new and traditional approaches. NY: Springer; 2005.
42.
43.
44.
Penzien DB, Holroyd KA. Psychosocial interventions in the management of recurrent headache disorders. 2: description of treatment techniques. Behav Med. 1994;20(2):64–73.CrossRefPubMed
45.
Nestoriuc Y, Martin A. Efficacy of biofeedback for migraine: a meta-analysis. Pain. 2007;128(1–2):111–27.CrossRefPubMed
46.
Blanchard EB et al. Migraine and tension headache: a meta-analytic review. Behav Ther. 1980;11(5):613–31.CrossRef
47.
Blanchard EB, Andrasik F. Biofeedback treatment of vascular headache. In: Hatch JGFJP, Rugh JD, editors. Biofeedback: studies in clinical efficacy. New York: Plenum Press; 1987.
48.
Holroyd KA, Penzien DB, Holm JE, Hursey KG. Behavioral treatment of recurrent headache: what does the literature say? In: American Association for the Study of Headache. San Francisco; 1984a, June.
49.
Beck AT et al. Cognitive therapy of depression. New York: Guilford Press; 1979. p. 425.
50.
Holroyd KA, Andrasik F. A cognitive-behavioral approach to recurrent tension and migraine headache. In: Kendall PE, editor. Advances in cognitive-behavioral research and therapy. New York: Academic; 1982. p. 276–320.
51.
McCarran MS, Andrasik F. Migraine and tension headaches. In: Michelson L, Ascher M, editors. Anxiety and stress disorders: cognitive-behavioral assessment and treatment. NY: Guilford; 1987. p. 465–483.
52.
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191–215.CrossRefPubMed
53.
Holroyd K et al. Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms. Cephalalgia. 2007;27:1156–65.CrossRefPubMedCentralPubMed
54.
French DJ et al. Perceived self-efficacy and headache-related disability. Headache. 2000;40(8):647–56.CrossRefPubMed
55.
56.
Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci. 2007;28 Suppl 2:S70–7.CrossRefPubMed
57.
Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback. 2002;27(2):163–81.CrossRefPubMed
58.
Blanchard EB et al. A controlled evaluation of the addition of cognitive therapy to a home-based biofeedback and relaxation treatment of vascular headache. Headache. 1990;30(6):371–6.CrossRefPubMed
59.
Mullally WJ, Hall K, Goldstein R. Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician. 2009;12(6):1005–11.PubMed
60.
Day MA et al. Mindfulness-based cognitive therapy for the treatment of headache pain: a pilot study. Clin J Pain. 2014;30(2):152–61.PubMed
61.
Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985;8(2):163–90.CrossRefPubMed
62.
Dorflinger L, et al. A partnered approach to opioid management, guideline concordant care and the stepped care model of pain management. J Gen Intern Med. 2014;29:870–6.
63.
Firth N, Barkham M, Kellett S. The clinical effectiveness of stepped care systems for depression in working age adults: a systematic review. J Affect Disord. 2014;170C:119–30.
64.
Buse DC et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260(8):1960–9. A review of the most recent evidence regarding common psychiatric comorbidities of both episodic and chronic migraine. CrossRefPubMed
65.
66.
Smitherman TA, Rains JC, Penzien DB. Psychiatric comorbidities and migraine chronification. Curr Pain Headache Rep. 2009;13(4):326–31.CrossRefPubMed
67.
Lanteri-Minet M et al. Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain. 2005;118(3):319–26.CrossRefPubMed
68.
69.
Wang SJ et al. Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain. 2001;89(2–3):285–92.CrossRefPubMed
70.
Seng EK, Holroyd KA. Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial. Cephalalgia. 2012;32(5):390–400. A study that demonstrates moderation of headache changes during preventive behavioral and pharmacotherapy by the presence of a depression and/or anxiety disorder. CrossRefPubMed
Metadata
Title
Behavioral Treatments for Migraine Management: Useful at Each Step of Migraine Care
Authors
Alexandra B. Singer
Dawn C. Buse
Elizabeth K. Seng
Publication date
01-04-2015
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 4/2015
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-015-0533-5

Other articles of this Issue 4/2015

Current Neurology and Neuroscience Reports 4/2015 Go to the issue

Sleep (M Thorpy, M Billiard, Section Editors)

Neurogenic Changes in the Upper Airway of Obstructive Sleep Apnoea

Neurotrauma (J Levine, Section Editor)

Concussion and Football: a Review and Editorial

Stroke (HP Adams, Section Editor)

The Relationship Between Herpes Zoster and Stroke

Neurology of Systemic Diseases (J Biller, Section Editor)

Neurological Counterparts of Hyponatremia: Pathological Mechanisms and Clinical Manifestations

Neuro-Oncology (LE Abrey, Section Editor)

Molecular Biology of Pediatric Brain Tumors and Impact on Novel Therapies

Stroke (HP Adams, Section Editor)

Dietary Interventions to Lower the Risk of Stroke